Neurogenic pain and steroid synthesis in the spinal cord

Journal of Molecular Neuroscience

Volumn 28, Issue 1, 2006, Pages 17-31

  Patte Mensah, Christine ^a   Kibaly, Cherkaouia ^a   Boudard, Domitille ^a   Schaeffer, Véronique ^a   Béglé, Aurélie ^a   Saredi, Simona ^a   Meyer, Laurence ^a   Mensah Nyagan, Ayikoe G ^a  

^a Hopitaux Universitaires de Strasbourg   (France)

Author keywords

Nervous system; Neuroprotection; Neurosteroid; Nociception; Pain; Sensory system; Spinal cord; Steroid

Indexed keywords

3ALPHA TETRAHYDROPROGESTERONE; 5ALPHA TETRAHYDROPROGESTERONE; CYTOCHROME P450; NEUROSTEROID; PREGNENOLONE; PROGESTERONE; PROGESTERONE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; BIOSYNTHESIS; CELLULAR DISTRIBUTION; ENZYME DEGRADATION; HUMAN; NERVE LIGATION; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PAIN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVIEW; SCIATIC NERVE; SENSORY SYSTEM; SPINAL CORD; STEROIDOGENESIS; UPREGULATION;

EID: 33646881342     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:28:1:17     Document Type: Review

References (165)

1. Abbaszade I. G., Arensburg J., Park C. H., Kasa-Vubu J. Z., Orly J., and Payne A. H. (1997) Isolation of a new mouse 3beta-hydroxysteroid dehydrogenase isoform, 3beta-HSD VI, expressed during early pregnancy. Endocrinology 138, 1392-1399.
2. Andersson S. and Russell D. W. (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proc. Natl. Acad. Sci. U. S. A. 87, 3640-3644.
3. Andersson S., Berman D. M., Jenkins E. P., and Russell D. W. (1991) Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354, 159-161.
4. Bartsch W., Klein H., Schiemann U., Bauer H. W., and Voigt K. D. (1990) Enzymes of androgen formation and degradation in the human prostate. Ann. N. Y. Acad. Sci. 595, 53-66.
5. Bauer H. C. and Bauer H. (1989) Micromethod for the determination of 3-beta-HSD activity in cultured cells. J. Steroid Biochem. 33, 643-646.
6. Baulieu E. E., Robel P., and Schumacher M. (1999) Contemporary Endocrinology, Humana Press, Totowa, NJ.
7. Bennett G. J. and Xie Y. K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87-107.
8. Berman D. M. and Russell D. W. (1993) Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes. Proc. Natl. Acad. Sci. U. S. A. 90, 9359-9363.
9. Brentano S. T., Picado-Leonard J., Mellon S. H., Moore C. C., and Miller W. L. (1990) Tissue-specific, cyclic adenosine 3′,5′-monophosphate- induced, and phorbol esterrepressed transcription from the human P450c17 promoter in mouse cells. Mol. Endocrinol. 4, 1972-1979.
10. Brot M. D., Akwa Y., Purdy R. H., Koob G. F., and Britton K. T. (1997) The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur. J. Pharmacol. 325, 1-7.
11. Cascio C., Prasad V. V., Lin Y. Y., Lieberman S., and Papadopoulos V. (1998) Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc. Natl. Acad. Sci. U. S. A. 95, 2862-2867.
12. Celotti F., Melcangi R. C., and Martini L. (1992) The 5 alpha-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocrinol. 13, 163-215.
13. Chung B. C., Matteson K. J., Voutilainen R., Mohandas T. K., and Miller W. L. (1986) Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc. Natl. Acad. Sci. U. S. A. 83, 8962-8966.
14. Chung B. C., Picado-Leonard J., Haniu M., Bienkowski M., Hall P. F., Shively J. E., and Miller W. L. (1987) Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. U. S. A. 84, 407-411.
15. Coirini H., Gouezou M., Liere P., Delespierre B., Pianos A., Eychenne B., et al. (2002) 3 Beta-hydroxysteroid dehydrogenase expression in rat spinal cord. Neuroscience 113, 883-891.
16. Compagnone N. A. and Mellon S. H. (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21, 1-56.
17. Compagnone N. A., Bulfone A., Rubenstein J. L., and Mellon S. H. (1995a) Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology 136, 2689-2696.
18. Compagnone N. A., Bulfone A., Rubenstein J. L., and Mellon S. H. (1995b) Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136, 5212-5223.
19. Corpéchot C., Robel P., Axelson M., Sjovall J., and Baulieu E. E. (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U. S. A. 78, 4704-4707.
20. Corpéchot C., Synguelakis M., Talha S., Axelson M., Sjovall J., Vihko R., et al. (1983) Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270, 119-125.
21. Dawson-Basoa M. and Gintzler A. R. (1997) Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res. 757, 37-42.
22. Dawson-Basoa M. and Gintzler A. R. (1998) Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems. Brain Res. 794, 61-67.
23. Di Blasio A. M., Voutilainen R., Jaffe R. B., and Miller W. L. (1987) Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 alpha-hydroxylase/17,20-lyase) in cultured human fetal adrenal cells. J. Clin. Endocrinol. Metab. 65, 170-175.
24. Dumont M., Luu-The V., Dupont E., Pelletier G., and Labrie F. (1992) Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J. Invest. Dermatol. 99, 41-421.
25. Dupont E., Simard J., Luu-The V., Labrie F., and Pelletier G. (1994) Localization of 3 beta-hydroxysteroid dehydrogenase in rat brain as studied by in situ hybridization. Mol. Cell. Neurosci. 5, 119-123.
26. Durkee T. J., McLean M. P., Hales D. B., Payne A. H., Waterman M. R., Khan I., and Gibori G. (1992) P450(17 alpha) and P450SCC gene expression and regulation in the rat placenta. Endocrinology 130, 1309-1317.
27. Frank C. and Sagratella S. (2000) Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog. Neuropsychopharmacol. Biol. Psychiatry 24, 1117-1126.
28. Frye C. A. (2001) The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Brain Res. Rev. 37, 201-222.
29. Frye C. A., Duncan J. E., Basham M., and Erskine M. S. (1996) Behavioral effects of 3 alpha-androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism. Behav. Brain Res. 79, 119-130.
30. Frye C. A., Rhodes M. E., Rosellini R., and Svare B. (2002) The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites. Pharmacol. Biochem. Behav. 74, 119-127.
31. Furukawa A., Miyatake A., Ohnishi T., and Ichikawa Y. (1998) Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450SCC (CYPXIA1), and 3beta-hydroxysteroid dehydrogenase in the rat brain. J. Neurochem. 71, 2231-2238.
32. Fuxe K. and Agnati L. F. (1992) Volume Transmission in the Brain: Novel Mechanisms for Neuronal Transmission, Raven Press, New York.
33. Gago N., Akwa Y., Sananes N., Guennoun R., Baulieu E. E., El-Etr M., and Schumacher M. (2001) Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism. Glia 36, 295-308.
34. Gago N., El-Etr M., Sananes N., Cadepond F., Samuel D., Avellana-Adalid V., et al. (2004) 3alpha,5alpha-Tetrahydroprogesterone (allopregnanolone) and gamma-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ progenitor proliferation. J. Neurosci. Res. 78, 770-783.
35. Gambhir M., Mediratta P. K., and Sharma K. K. (2002) Evaluation of the analgesic effect of neurosteroids and their possible mechanism of action. Indian J. Physiol. Pharmacol. 46, 202-208.
36. Ghoumari A. M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B. W., et al. (2003) Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86, 848-859.
37. Giachino C., Galbiati M., Fasolo A., Peretto P., and Melcangi R. C. (2004) Effects of progesterone derivatives, dihydroprogesterone and tetrahydroprogesterone, on the subependymal layer of the adult rat. J. Neurobiol. 58, 493-502.
38. Gonzalez Deniselle M. C., Lopez-Costa J. J., Saavedra J. P., Pietranera L., Gonzalez S. L., Garay L., et al. (2002) Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11, 457-468.
39. Goodchild C. S., Guo Z., and Nadeson R. (2000) Antinociceptive properties of neurosteroids I. Spinally-mediated antinociceptive effects of water-soluble aminosteroids. Pain 88, 23-29.
40. Goodchild C. S., Robinson A., and Nadeson R. (2001) Antinociceptive properties of neurosteroids IV: pilot study demonstrating the analgesic effects of alphadolone administered orally to humans. Br. J. Anaesth. 86, 528-534.
41. Greco T. L. and Payne A. H. (1994) Ontogeny of expression of the genes for steroidogenic enzymes P450 side-chain cleavage, 3 beta-hydroxysteroid dehydrogenase, P450 17 alpha-hydroxylase/C17-20lyase, and P450 aromatase in fetal mouse gonads. Endocrinology 135, 262-268.
42. Guennoun R., Fiddes R. J., Gouezou M., Lombes M., and Baulieu E. E. (1995) A key enzyme in the biosynthesis of neurosteroids, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase (3 beta-HSD), is expressed in rat brain. Brain Res. Mol. Brain Res. 30, 287-300.
43. Guennoun R., Schumacher M., Robert F., Delespierre B., Gouezou M., Eychenne B., et al. (1997) Neurosteroids: expression of functional 3beta-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells. Eur. J. Neurosci. 9, 2236-2247.
44. Guth L., Zhang Z., and Roberts E. (1994) Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 91, 12308-12312.
45. Haines D. E., Mihailoff G. A., and Yezierski R. P. (1997) The spinal cord, in Fundamental Neuroscience, Haines D. E., ed., Churchill Livingstone, New York, pp. 129-141.
46. Hales D. B. (1992) Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression. Endocrinology 131, 2165-2172.
47. Hales D. B., Sha L. L,. and Payne A. H. (1987) Testosterone inhibits cAMP-induced de novo synthesis of Leydig cell cytochrome P-450 (17 alpha) by an androgen receptor-mediated mechanism. J. Biol. Chem. 262, 11200-11206.
48. Hodge C. W., Raber J., McMahon T., Walter H., Sanchez-Perez A. M., Olive M. F., et al. (2002) Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 110, 1003-1010.
49. Hojo Y., Hattori T. A., Enami T., Furukawa A., Suzuki K., Ishii H. T., et al. (2004) Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U. S. A. 101, 865-870.
50. Ikushiro S., Kominami S., and Takemori S. (1992) Adrenal P-450scc modulates activity of P-45011 beta in liposomal and mitochondrial membranes. Implication of P-450scc in zone specificity of aldosterone biosynthesis in bovine adrenal. J. Biol. Chem. 267, 1464-1469.
51. Jenkins E. P., Andersson S., Imperato-McGinley J., Wilson J. D., and Russell D. W. (1992) Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J. Clin. Invest. 89, 293-300.
52. Jez J. M. and Penning T. M. (2001) The aldo-keto reductase (AKR) superfamily: an update. Chem. Biol. Interact. 130-132, 499-525.
53. Jez J. M., Bennett M. J., Schlegel B. P., Lewis M., and Penning T. M. (1997a) Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 326(Pt. 3), 625-636.
54. Jez J. M., Flynn T. G., and Penning T. M. (1997b) A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54, 639-647.
55. Jez J. M., Schlegel B. P., and Penning T. M. (1996) Characterization of the substrate binding site in rat liver 3alpha-hydroxysteroid/dihydrodiol dehydrogenase. The roles of tryptophans in ligand binding and protein fluorescence. J. Biol. Chem. 271, 30190-30198.
56. Joseph E. K. and Levine J. D. (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci. 20, 2896-2902.
57. Julius D. and Basbaum A. I. (2001) Molecular mechanisms of nociception. Nature 413, 203-210.
58. Jung-Testas I., Hu Z. Y., Baulieu E. E., and Robel P. (1989) Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 125, 2083-2091.
59. Kastrup Y., Hallbeck M., Amandusson A., Hirata S., Hermanson O., and Blomqvist A. (1999) Progesterone receptor expression in the brainstem of the female rat. Neurosci. Lett. 275, 85-88.
60. Kennedy P. G. (1982) Neural cell markers and their applications to neurology. J. Neuroimmunol. 2, 35-53.
61. Khanna M., Qin K. N., and Cheng K. C. (1995) Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans. J. Steroid Biochem. Mol. Biol. 53, 41-46.
62. Kibaly C., Patte-Mensah C., and Mensah-Nyagan A.G. (2005) Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J. Neurochem. 93, 1220-1230.
63. Kimonides V. G., Khatibi N. H., Svendsen C. N., Sofroniew M. V., and Herbert J. (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95, 1852-1857.
64. Koenig H. L., Schumacher M., Ferzaz B., Thi A. N., Ressouches A., Guennoun R., et al. (1995) Progesterone synthesis and myelin formation by Schwann cells. Science 268, 1500-1503.
65. Kohchi C., Ukena K., and Tsutsui K. (1998) Age- and region-specific expressions of the messenger RNAs encoding for steroidogenic enzymes p450scc, P450c17 and 3beta-HSD in the postnatal rat brain. Brain Res. 801, 233-238.
66. Koltzenburg M. (1998) Painful neuropathies. Curr. Opin. Neurol. 11, 515-521.
67. Krieger N. R. and Scott R. G. (1984) 3 alpha-Hydroxysteroid oxidoreductase in rat brain. J. Neurochem. 42, 887-890.
68. Krieger N. R. and Scott R. G. (1989) Nonneuronal localization for steroid converting enzyme: 3 alpha-hydroxysteroid oxidoreductase in olfactory tubercle of rat brain. J. Neurochem. 52, 1866-1870.
69. Kuhn-Velten W. N. and Lessmann M. (1992) Ketoconazole inhibition of the bifunctional cytochrome P450c17 does not affect androgen formation from the endogenous lyase substrate. The catalytic site remains refractory in the course of intermediary hydroxyprogesterone processing. Biochem. Pharmacol. 44, 2371-2378.
70. Labombarda F., Guennoun R., Gonzalez S., Roig P., Lima A., Schumacher M., and De Nicola A. F. (2000) Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord. Neurosci. Lett. 288, 29-32.
71. Lambert J. J., Belelli D., Peden D. R., Vardy A. W., and Peters J. A. (2003) Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71, 67-80.
72. Le Goascogne C., Robel P., Gouezou M., Sananes N., Baulieu E. E., and Waterman M. (1987) Neurosteroids: cytochrome P-450scc in rat brain. Science 237, 1212-1215.
73. Lumbroso S., Sandillon F., Georget V., Lobaccaro J. M., Brinkmann A. O., Privat A., and Sultan C. (1996) Immunohistochemical localization and immunoblotting of androgen receptor in spinal neurons of male and female rats. Eur. J. Endocrinol. 134, 626-632.
74. Luu-The V., Lachance Y., Labrie C., Leblanc G., Thomas J. L., Strickler R. C., and Labrie F. (1989) Full length cDNA structure and deduced amino acid sequence of human 3 beta-hydroxy-5-ene steroid dehydrogenase. Mol. Endocrinol. 3, 1310-1312.
75. Luu-The V., Sugimoto Y., Puy L., Labrie Y., Lopez Solache I., Singh M., and Labrie F. (1994) Characterization, expression, and Immunohistochemical localization of 5 alpha-reductase in human skin. J. Invest. Dermatol. 102, 221-226.
76. Maione S., Siniscalco D., Galderisi U., de Novellis V., Uliano R., Di Bernardo G., et al. (2002) Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat. Neuroreport 13, 101-106.
77. Majewska M. D. (1992) Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38, 379-395.
78. Martini L., Celotti F., and Melcangi R. C. (1996) Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved. Cell. Mol. Neurobiol. 16, 271-282.
79. Martini L., Magnaghi V., and Melcangi R. C. (2003) Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system. Steroids 68, 825-829.
80. Mason J. I. (1993) The 3β-hydroxysteroid dehydrogenase gene family of enzymes. Trends Endocrinol. Metab. 4, 199-203.
81. Mathieu M., Mensah-Nyagan A. G., Vallarino M., Do-Rego J. L., Beaujean D., Vaudry D., et al. (2001) Immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase in the brain of the African lungfish Protopterus annectens. J. Comp. Neurol. 438, 123-135.
82. Matsumoto A. (1997) Hormonally induced neuronal plasticity in the adult motoneurons. Brain Res. Bull. 44, 539-547.
83. Matteson K. J., Chung B. C., Urdea M. S., and Miller W. L. (1986) Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes. Endocrinology 118, 1296-1305.
84. Matus A. (1990) Microtubule-associated proteins. Curr. Opin. Cell. Biol. 2, 10-14.
85. Mayo W., Dellu F., Robel P., Cherkaoui J., Le Moal M., Baulieu E. E., and Simon H. (1993) Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607, 324-328.
86. McEwen B. S. (1994) Endocrine effects on the brain and their relationship to behavior, in Basic Neurochemistry, Siegel, G. J., Agranoff, B. W., Albers, R. W., and Molinoff B., eds., Raven Press, New York, pp. 1003-1023.
87. Melcangi R. C., Ballabio M., Cavarretta I., Gonzalez L. C., Leonelli E., Veiga S., et al. (2003) Effects of neuroactive steroids on myelin of peripheral nervous system. J. Steroid Biochem. Mol. Biol. 85, 323-327.
88. Melcangi R. C., Celotti F., Ballabio M., Castano P., Poletti A., Milani S., and Martini L. (1988a) Ontogenetic development of the 5a-reductase in the rat brain: cerebral cortex, hypothalamus, purified myelin and isolated oligodendrocytes. Dev. Brain Res. 44, 181-188.
89. Melcangi R. C., Celotti F., Ballabio M., Poletti A., Castano P., and Martini L. (1988b) Testosterone 5a-reductase activity in the rat brain is highly concentrated in white matter structures and in purified myelin sheaths of axons. J. Steroid Biochem. 31, 173-179.
90. Melcangi R. C., Celotti F., Castano P., and Martini L. (1993) Differential localization of the 5 alpha-reductase and the 3 alpha-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology 132, 1252-1259.
91. Melcangi R. C., Poletti A., Cavarretta I., Celotti F., Colciago A., Magnaghi V., et al. (1998) The 5alpha-reductase in the central nervous system: expression and modes of control. J. Steroid Biochem. Mol. Biol. 65, 295-299.
92. Mellon S. H. and Deschepper C. F. (1993) Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629, 283-292.
93. Mensah-Nyagan A. G., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. (2001a) Anatomical and biochemical evidence for the synthesis of unconjugated and sulfated neurosteroids in amphibians. Brain Res. Brain Res. Rev. 37, 13-24.
94. Mensah-Nyagan A. G., Do-Rego J. L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. (1999) Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51, 63-81.
95. Mensah-Nyagan A. G., Do-Rego J. L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. (2001b) Regulation of neurosteroid biosynthesis in the frog diencephalon by GABA and endozepines. Horm. Behav. 40, 218-225.
96. Mensah-Nyagan A. G., Do-Rego J. L., Feuilloley M., Marcual A., Lange C., Pelletier G., and Vaudry H. (1996a) In vivo and in vitro evidence for the biosynthesis of testosterone in the telencephalon of the female frog. J. Neurochem. 67, 413-422.
97. Mensah-Nyagan A. M., Feuilloley M., Do-Rego J. L., Marcual A., Lange C., Tonon M. C., et al. (1996b) Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U. S. A. 93, 1423-1428.
98. Mensah-Nyagan A. G., Feuilloley M., Dupont E., Do-Rego J. L., Leboulenger F., Pelletier G., and Vaudry H. (1994) Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci. 14, 7306-7318.
99. Millan M. J. (1999) The induction of pain: an integrative review. Prog. Neurobiol. 57, 1-164.
100. Morohashi K., Sogawa K., Omura T., and Fujii-Kuriyama Y. (1987) Gene structure of human cytochrome P-450(SCC), cholesterol desmolase. J. Biochem. (Tokyo) 101, 879-887.
101. Mowszowicz I., Berthauit I., Mestayer C., Wright F., Kuttenn F., and Mauvais-Jarvis P. (1995) [5-alpha-reductases: physiology and pathology]. Ann. Endocrinol. (Paris) 56, 555-559.
102. Murakami K., Fellous A., Baulieu E. E., and Robel P. (2000) Pregnenolone binds to microtubule-associated protein 2 and stimulatesmicrotubule assembly. Proc. Natl. Acad. Sci. U. S. A. 97, 3579-3584.
103. Nagle R. B. (1988) Intermediate filaments: a review of the basic biology. Am. J. Surg. Pathol. 12(Suppl. 1), 4-16.
104. Negri-Cesi P., Poletti A., and Celotti F. (1996) Metabolism of steroids in the brain: a new insight into the role of 5alpha-reductase and aromatase in brain differentiation and functions. J. Steroid Biochem. Mol. Biol. 58, 455-466.
105. Normington K. and Russell D. W. (1992) Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions. J. Biol. Chem. 267, 19548-19554.
106. Oonk R. B., Parker K. L., Gibson J. L., and Richards J. S. (1990) Rat cholesterol side-chain cleavage cytochrome P-450 (P-450scc) gene. Structure and regulation by cAMP in vitro. J. Biol. Chem. 265, 22392-22401.
107. Patchev V. K., Hassan A. H., Holsboer D. F., and Almeida O. F. (1996) The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15, 533-540.
108. Patte-Mensah C., Kappes V., Freund-Mercier M. J., Tsutsui K., and Mensah-Nyagan A. G. (2003) Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J. Neurochem. 86, 1233-1246.
109. Patte-Mensah C., Kibaly C., and Mensah-Nyagan A. G. (2005) Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. Proc. Natl. Acad. Sci. U. S. A. 102, 9044-9049.
110. Patte-Mensah C., Li S., and Mensah-Nyagan A. G. (2004a) Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell. Mol. Life Sci. 61, 2274-2284.
111. Patte-Mensah C., Penning T. M., and Mensah-Nyagan A. G. (2004b) Anatomical and cellular localization of neuroactive 5alpha/3alpha-reduced steroid-synthesizing enzymes in the spinal cord. J. Comp. Neurol. 477, 286-299.
112. Paul S. M. and Purdy R. H. (1992) Neuroactive steroids. FASEB J. 6, 2311-2322.
113. Pawlowski J. E., Huizinga M., and Penning T. M. (1991) Cloning and sequencing of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. J. Biol. Chem. 266, 8820-8825.
114. Payne A. H. and Hales D. B. (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25, 947-970.
115. Pelletier G., Luu-The V., and Labrie F. (1994) Immunocytochemical localization of 5alpha-reductase in rat brain. Mol. Cell. Neurosci. 5, 394-399.
116. Penning T. M., Jin Y., Heredia V. V., and Lewis M. (2003) Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms. J. Steroid Biochem. Mol. Biol. 85, 247-255.
117. Plassart-Schiess E. and Baulieu E. E. (2001) Neurosteroids: recent findings. Brain Res. Brain Res. Rev. 37, 133-140.
118. Poletti A., Celotti F., Rumio C., Rabuffetti M., and Martini L. (1997) Identification of type 1 5alpha-reductase in myelin membranes of male and female rat brain. Mol. Cell. Endocrinol. 129, 181-190.
119. Poletti A., Coscarella A., Negri-Cesi P., Colciago A., Celotti F., and Martini L. (1998a) 5 alpha-reductase isozymes in the central nervous system. Steroids 63, 246-251.
120. Poletti A., Negri-Cesi P., Rabuffetti M., Colciago A., Celotti F., and Martini L. (1998b) Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life. Endocrinology 139, 2171-2178.
121. Pozzi P., Bendotti C., Simeoni S., Piccioni F., Guerini V., Marron T. U., et al. (2003) Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones. J. Neuroendocrinol. 15, 882-887.
122. Prasad V. V., Vegesna S. R., Welch M., and Lieberman S. (1994) Precursors of the neurosteroids. Proc. Natl. Acad. Sci. U. S. A. 91, 3220-3223.
123. Purdy R. H., Morrow A. L., Moore P. H. Jr., and Paul S. M. (1991) Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U. S. A. 88, 4553-4557.
124. Raff M. C., Mirsky R., Fields K. L., Lisak R. P., Dorfman S. H., Silberberg D. H., et al. (1978) Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 274, 813-816.
125. Reddy D. S. (2003) Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol. Sci. 24, 103-106.
126. Rhéaume E., Lachance Y., Zhao H. F., Breton N., Dumont M., de Launoit Y., et al. (1991) Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol. Endocrinol. 5, 1147-1157.
127. Robert F., Guennoun R., Desarnaud F., Do-Thi A., Benmessahel Y., Baulieu E. E., and Schumacher M. (2001) Synthesis of progesterone in Schwann cells: regulation by sensory neurons. Eur. J. Neurosci. 13, 916-924.
128. Roby K. F., Larsen D., Deb S., and Soares M. J. (1991) Generation and characterization of antipeptide antibodies to rat cytochrome P-450 side-chain cleavage enzyme. Mol. Cell. Endocrinol. 79, 13-20.
129. Rupprecht R., di Michele F., Hermann B., Strohle A., Lancel M., Romeo E., and Holsboer F. (2001) Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Brain Res. Rev. 37, 59-67.
130. Saitoh H., Hirato K., Yanaihara T., and Nakayama T. (1982) A study of 5 alpha-reductase in human fetal brain. Endocrinol. Jpn. 29, 461-467.
131. Sakamoto H., Ukena K., and Tsutsui K. (2001a) Activity and localization of 3beta-hydroxysteroid dehydrogenase/ Delta5-Delta4-isomerase in the zebrafish central nervous system. J. Comp. Neurol. 439, 291-305.
132. Sakamoto H., Ukena K., and Tsutsui K. (2002) Dendritic spine formation in response to progesterone synthesized de novo in the developing Purkinje cell in rats. Neurosci. Lett. 322, 111-115.
133. Sakamoto H., Ukena K., and Tsutsui K. (2001b) Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis. J. Neurosci. 21, 6221-6232.
134. Sanne J. L. and Krueger K. E. (1995) Expression of cytochrome P450 side-chain cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J. Neurochem. 65, 528-536.
135. Schumacher M., Guennoun R., Robert F., Carelli C., Gago N., Ghoumari A., et al. (2004) Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF Res. 14(Suppl. A), S18-S33.
136. Simard J., Durocher F., Mebarki F., Turgeon C., Sanchez R., Labrie Y., et al. (1996) Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. J. Endocrinol. 150(Suppl.), S189-S207.
137. Smithgall T. E. and Penning T. M. (1988) Electrophoretic and immunochemical characterization of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenases of rat tissues. Biochem. J. 254, 715-721.
138. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Ludwig M., Clusmann H., Bidlingmaier F., et al. (2003) Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res. 54, 11-19.
139. Ströhle A., Pasini A., Romeo E., Hermann B., Spalletta G., di Michele F., et al. (2000) Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. J. Psychiatr. Res. 34, 183-186.
140. Strömstedt M. and Waterman M. R. (1995) Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Brain Res. Mol. Brain Res. 34, 75-88.
141. Suhara K., Gomi T., Sato H., Itagaki E., Takemori S., and Katagiri M. (1978) Purification and immunochemical characterization of the two adrenal cortex mitochondrial cytochrome P-450-proteins. Arch. Biochem. Biophys. 190, 290-299.
142. Swart P., Swart A. C., Waterman M. R., Estabrook R. W., and Mason J. I. (1993) Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 77, 98-102.
143. Thigpen A. E., Cala K. M., and Russell D. W. (1993) Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes. J. Biol. Chem. 268, 17404-17412.
144. Thomas A. J., Nockels R. P., Pan H. Q., Shaffrey C. I., and Chopp M. (1999) Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24, 2134-2138.
145. Torres J. M. and Ortega E. (2003) Differential regulation of steroid 5alpha-reductase isozymes expression by androgens in the adult rat brain. FASEB J. 17, 1428-1433.
146. Tsutsui K. and Yamazaki T. (1995) Avian neurosteroids. I. Pregnenolone biosynthesis in the quail brain. Brain Res. 678, 1-9.
147. Ukena K., Honda Y., Inai Y., Kohchi C., Lea R. W., and Tsutsui K. (1999) Expression and activity of 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4- isomerase in different regions of the avian brain. Brain Res. 818, 536-542.
148. Ukena K., Honda Y., Lea R. W., and Tsutsui K. (2001) Developmental changes in progesterone biosynthesis and metabolism in the quail brain. Brain Res. 898, 190-194.
149. Ukena K., Usui M., Kohchi C., and Tsutsui K. (1998) Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neonatal change in rats. Endocrinology 139, 137-147.
150. Usui M., Yamazaki T., Kominami S., and Tsutsui K. (1995) Avian neurosteroids. II. Localization of a cytochrome P450scc-like substance in the quailbrain. Brain Res. 678, 10-20.
151. Uzunova V., Sheline Y., Davis J. M., Rasmusson A., Uzunov D. P., Costa E., and Guidotti A. (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U. S. A. 95, 3239-3244.
152. Vallée M., Mayo W., Darnaudery M., Corpechot C., Young J., Koehl M., et al. (1997) Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 94, 14865-14870.
153. Vallée M., Mayo W., Koob G. F., and Le Moal M. (2001) Neurosteroids in learning and memory processes. Int. Rev. Neurobiol. 46, 273-320.
154. Van Broekhoven F. and Verkes R. J. (2003) Neurosteroids in depression: a review. Psychopharmacology (Berl.) 165, 97-110.
155. Weidenfield J., Sziegel R. A., and Chowers I. (1980) In vitro conversion of pregnenolone to progesterone by discrete brain areas of the male rat. J. Steroid Biochem. 13, 961-963.
156. Whiteside G. T. and Munglani R. (2001) Cell death in the superficial dorsal horn in a model of neuropathic pain. J. Neurosci. Res. 64, 168-173.
157. Willis W. D., Westlund K. N., and Carlton S. M. (1995) Pain, in The Rat Nervous System, 2nd ed., Paxinos, G., ed., Academic Press, Sydney, pp. 725-750.
158. Wilson J. D., Griffin J. E., and Russell D. W. (1993) Steroid 5 alpha-reductase 2 deficiency. Endocr. Rev. 14, 577-593.
159. Winter L., Nadeson R., Tucker A. P., and Goodchild C. S. (2003) Antinociceptive properties of neurosteroids: a comparison of alphadolone and alphaxalone in potentiation of opioid antinociception. Anesth. Analg. 97, 798-805.
160. Woolf C. J. and Mannion R. J. (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959-1964.
161. Woolf C. J. and Salter M. W. (2000) Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1769.
162. Yu L., Romero D. G., Gomez-Sanchez C. E., and Gomez-Sanchez E. P. (2002) Steroidogenic enzyme gene expression in the human brain. Mol. Cell. Endocrinol. 190, 9-17.
163. Zhao H. F., Rhéaume E., Trudel C., Couet J., Labrie F., and Simard J. (1990) Structure and sexual dimorphic expression of a liver-specific rat 3 beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology 127, 3237-3239.
164. Zhao H. F., Labrie C., Simard J., de Launoit Y., Trudel C., Martel C., et al. (1991) Characterization of rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues. J. Biol. Chem. 266, 583-593.
165. Zimmerberg B. and Brown R. C. (1998) Prenatal experience and postnatal stress modulate the adult neurosteroid and catecholaminergic stress responses. Int. J. Dev. Neurosci. 16, 217-228.